Patent ID: 7652066

Claim:
A method of treating a patient having leukemia, lymphoma, carcinoma, sarcoma, breast cancer, lung cancer, head and neck cancer, rectal cancer, or bladder cancer comprising administering to the patient in need thereof an effective amount of a compound of general formula (I): (i) wherein X 30 is selected from the group consisting of N + (R 1 , R 2 , R 3 ), and P 30 (R 1 , R 2 , R 3 ), wherein R 1 , R 2 and R 3 , which are the same or different, are selected from the group consisting of hydrogen and C 1 -C 9 straight or branched alkyl groups, —CH═NH(NH 2 ), —NH 2 , and —OH; with the proviso that at least one of R 1 , R 2 and R 3 is different from hydrogen; (ii) Z is selected from the group consisting of —OR 4 , —OCOOR 4 , —OCONHR 4 , —OCSNHR 4 , —OCSOR 4 , —NHR 4 , —NHCOR 4 , —NHCSR 4 , —NHCOOR 4 , —NHCSOR 4 , —NHCONHR 4 , —NHCSNHR 4 , —NHSOR 4 , —NHSONHR 4 , —NHSO 2 R 4 , —NHSO 2 NHR 4 , and —SR 4 , wherein R 4 is a C 2 -C 20 saturated or unsaturated, straight or branched alkyl group; (iii) Y − is selected from the group consisting of —COO − , —PO 3 H, —OPO 3 H − , and tetrazolate-5-yl; a salt, enantiomer or racemic mixture thereof.